Luoxin Pharmaceutical: Announcement on the implementation of the 2021 annual distribution of rights
Luoxin Pharmaceutical: Announcement on major asset swaps and issuance of shares to purchase assets and the impairment test of assets placed in related transactions at the end of 2021
Luoxin Pharmaceutical: Announcement on 2021 Profit Distribution Plan
Luo Xin Pharmaceutical: China Chengxin International's Announcement on Termination of Credit Ratings for Company Entities and Debts
Luoxin Pharmaceutical: Announcement on the delisting of “Dongyin Transfer Bonds”
Luoxin Pharmaceutical: Announcement on the “Dongyin Transfer Bonds” redemption results
Luoxin Pharmaceutical: 22nd Prompt Notice on the Implementation of “Dongyin Transfer Bonds” Redemption
Luoxin Pharmaceutical: 21st Prompt Notice on the Implementation of “Dongyin Transfer Bonds” Redemption
Luo Xin Pharmaceutical: The 19th Prompt Notice on the Implementation of “Dongyin Transfer Bonds” Redemption
Luoxin Pharmaceutical: 18th Prompt Notice on the Implementation of “Dongyin Transfer Bonds” Redemption
Luoxin Pharmaceutical: 17th Prompt Notice on the Implementation of “Dongyin Transfer Bonds” Redemption
Luoxin Pharmaceutical: 16th Prompt Notice on the Implementation of “Dongyin Transfer Bonds” Redemption
Luoxin Pharmaceutical: 15th Reminder Announcement on the Implementation of “Dongyin Transfer Bonds” Redemption
Luoxin Pharmaceutical: 14th Prompt Notice on the Implementation of “Dongyin Transfer Bonds” Redemption
Luo Xin Pharmaceutical: 13th Prompt Notice on the Implementation of “Dongyin Transfer Bonds” Redemption
Luo Xin Pharmaceutical: 12th Prompt Notice on the Implementation of “Dongyin Transfer Bonds” Redemption and Suspension of Trading
Luoxin Pharmaceutical: 11th Reminder Notice on the Implementation of “Dongyin Transfer Bonds” Redemption and Suspension of Trading
Luoxin Pharmaceutical: Tenth Reminder Notice on the Implementation of “Dongyin Transfer Bonds” Redemption and Suspension of Trading
Luoxin Pharmaceutical: Ninth Reminder Notice on the Implementation of “Dongyin Transfer Bonds” Redemption and Suspension of Trading
Luoxin Pharmaceutical: Announcement on the face value of “Dongyin Transfer Bonds” falling below 30 million yuan and will stop trading
No Data
No Data